Men in white coat in media briefing. Photo by Unsplash
©️ Photo by Tedward Quinn on Unsplash

NCD Alliance hosts media briefing on COVID-19 and NCDs

04th May 2020

The NCD Alliance invited media representatives to an on-the-record briefing on COVID-19 and NCDs: Lessons learned from around the world. 

The media telebriefing took place on 29th April 2020 and provided an opportunity to discuss best practices and lessons learned so far in selected countries. This included:

  • Emerging evidence from the COVID-19 pandemic shows many intersections between COVID-19 and NCDs. People living with NCDs (PLWNCDs) are more vulnerable to COVID-19, with a substantially higher risk of becoming severely ill or dying from the virus;
  • People with COVID-19 infection and cardiovascular disease, hypertension and diabetes are at least twice as likely to die;
  • Smoking is especially deadly – the evidence base is clearly still in development, but one study found that smokers have 14 times greater odds of developing COVID-associated pneumonia than non-smokers;
  • People with comprised immune systems (ongoing cancer treatment, diabetes, COPD, people on steroid treatment, etc.) are at higher risk of developing complications from COVID-19;
  • People living with three or more co-morbidities (hypertension, diabetes, COPD/asthma, TB, obesity, smokers) are at higher risk of developing complications from COVID-19.
Attendees included Katie Dain - CEO of NCD Alliance, Bente Mikkelsen - Director of NCD Department at World Health Organisation (WHO), Ole Alexsander Opdalshei - Secretary General Assistant of Norwegian Cancer Society, Vicky Pinkney-Atkinson - a person living with various NCDs (psoriasis & immune compromised) and Director of South Africa NCD Alliance, Johanna Ralston - CEO of World Obesity Federation, Monika Arora - Executive Director of Healthy India Alliance and Ibithal Fadhil - President of Eastern Mediterranean NCD Alliance.
The media briefing recording is now available to listen here
For any media related information please contact Michael Kessler at [email protected]